🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Beatriz Sánchez‐Solana

Center for Devices and Radiological Health

ORCID: 0000-0003-1155-5194

Also affiliated with National Cancer Institute

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function”.

Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function

Cancer Research(2020)10.1158/0008-5472.can-19-3984
N/A
0DataRank · unranked
24 citations

Xiaolan Qian, Beatriz Sánchez‐Solana, Brajendra K. Tripathi, Marian E. Durkin, Douglas R. Lowy +1 more

The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1

Molecular Cancer(2021)10.1186/s12943-021-01439-y
N/A
0DataRank · unranked
27 citations

Dunrui Wang, Xiaolan Qian, Velayoudame Parthibane, Dhirendra K. Simanshu, Jairaj Acharya +2 more

A cancer-associated K-RAS mutant that preferentially binds GDP displays gain-of-function and atypical signaling

Research Square(2022)10.21203/rs.3.rs-1521657/v1
N/A
0DataRank · unranked
1 citations

Tatu Pantsar, Alex G. Papageorge1, Brajendra K. Tripathi, Beatriz Sánchez‐Solana, Marian E. Durkin +8 more

cProSite: A Web Based Interactive Platform for Online Proteomics, Phosphoproteomics, and Genomics Data Analysis

Journal of Biotechnology and Biomedicine(2023)10.26502/jbb.2642-91280119
N/A
0DataRank · unranked
42 citations

Xiaolan Qian, Yi‐Chieh Nancy Du, Beatriz Sánchez‐Solana, Dunrui Wang

FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0883
N/A
0DataRank · unranked
0 citations

Dow-Chung Chi, Sundeep Agrawal, Hee‐Koung Joeng, Sarah Kim-McOlash, Wimolnut Manheng +17 more